Bend Research Release: New Technology for Producing Thermostable Vaccines  
11/28/2012 9:28:35 AM

BEND, Ore. & SEATTLE & NEWARK, Del.--(BUSINESS WIRE)--Bend Research Inc., PATH, and Fraunhofer USA Center for Molecular Biotechnology (FhCMB) announce the development of a new technology for the production of thermostable vaccines. Utilizing novel formulation and spray-drying processing methods, the technology has enabled scientists at Bend Research, PATH, and FhCMB to develop a spray-dried influenza vaccine product that is stable at 50°C for over 2 months. The technology can also be applied to emerging influenza and other vaccines.